Gout arthritis has two characteristics, involving the inflammasome's activation and the MSU-induced generation of mature IL-1β[5]. The NLRP3 inflammasome requires activation by two separate signals in order to create mature IL-1β[18]. The initial signal that sets off the activation of the NLRP3 inflammasome is still unknown. When considering the mechanism behind uric acid-induced gouty inflammation, it is vital to understand how other pro-inflammatory chemicals recognize MSU-mediated inflammasome activation and IL-1β[19]. In addition to IL-1β, GA is a condition characterized by inflammation where urate crystals result in the activation of white blood cells[20].

The examination of serum Interleukin-1 concentrations in gout patients and healthy controls is provided in Table (3) and Figure (2) as research findings. The level was substantially greater in the "patients group" as comparison to the healthy control (P 0.001), and the mean serum IL-1 levels were 781.88 314.45 pg/ml and 316.79 94.85 pg/ml, respectively, in gouty patients and healthy controls.

The findings of this study concur with those of Martinon et al, who demonstrated that monosodium urate crystals activated caspase-1, which in turn caused NALP3 to become active and increased levels of active interleukin IL-1β[9].

The pathophysiology for gouty inflammation is associated with a growing and activation the NLRP3 inflammasome, which is a protein that contains the LRR, NOD, and pyrin domains. This inflammasome then produces proinflammatory cytokines.

It is cannot to ascribe the stimulation of inflammasome component assembly and expression to MSU crystals alone. Preparing macrophages produced from monocytes is the earliest sign of gouty inflammation. The second signal, which is brought on by MSU crystals, causes multiprotein intracellular inflammasomes of NLRP3 to form, which include pro-caspase 1. Then, to make the active versions, active caspase 1 cleaves molecules like IL-1β and other precursors. When IL-1β is released, neutrophils are drawn to the area of inflammation, more pro-inflammatory cytokines are produced, and cartilage and bone are degraded[21].

In addition, the irisin was first recognized In 2012, Bostrom postulated that skeletal muscle secretes this hormone in response to exercise[22]. Functional studies have shown that irisin is easily measurable in serum and may circulate through white adipose tissue, which may cause a transition from white within brown-like adipose tissue because brown adipose tissue is skilled at releasing energy by creating heat[23]. Irisin is very useful for treating several metabolic illnesses, including diabetes, nonalcoholic fatty liver, metabolic syndrome, and obesity[24][25][26]. Myokine and AMP-activated protein kinase (AMPK), two important metabolic regulators, are also activated by exercise. Additionally, PGC1-a can be directly phosphorylated by AMPK[27], activating FNDC5 and increasing serum irisin levels. Irisin controls chondrocyte proliferation and mortality while preserving the extra chondral matrix's integrity, which can have a direct impact on the development of osteoarthritis. The extracellular matrix degrades and chondrocytes die as a result of the osteoarthritis (OA) inflammatory process[28].

In this study, the usefulness of serum irisin, a novel potentially protein biomarker, as a predictor of gout activity, was investigated in relation to other parameters in Figure(3) and Table (4), Mean levels of serum Irisin were 6.76 ± 2.91 ng/ml and 17.03 ± 4.14 ng/ml, in gouty patients and healthy control respectively; and the level was highly significantly lower than in "patients group" in comparison with healthy control (P < 0.001).

We contrasted gout, a severe type of arthritis, to osteoarthritis, where early studies on the association between the irisin levels and the condition employed serum samples from individuals with knee discomfort. There was shown to be a negative connection between serum irisin concentration and the severity of osteoarthritis when those levels dropped[29][30].This study is also in accordance with research on the effects of irisin on the skeleton, which revealed a link between vertebral fragility fractures and low irisin levels in postmenopausal women. Yet, in athletes, The concentrations were directly correlated with bone mass and density, demonstrating irisin's preventative function in bone health[31]. But nonetheless, the central nervous system is also affected by the irisin action. Irisin received interest due to its potential use in treating neurodegenerative illnesses like Alzheimer's and Parkinson's[32][33].

Several variables, body mass index (BMI), including gender, muscle mass, age, and training, have an impact on irisin serum levels[34]. Also, the findings of the Pearson correlation study revealed that irisin and IL- 1β have a negative association, where R (-0.080), p (0.481). Irisin is negatively correlation with Uric Acid where

R ( -0.023),p (0.842). As well as The correlation was positive between IL-1β and Uric Acid where R (0.101 ), p (0.895)as shown in Table (5).

Also, the ROC curve analysis findings were displayed in Tables (6). (7) and Figure (4), (5) that the AUC(95%CI) for serum IL-1β and irisin was 0.990(0.979-1.000) , 0.999(0.996-1.000) respectively, Both serum IL-1β and irisin are the preferred biomarkers for the diagnosis of gout, and it has been demonstrated that both are useful in distinguishing gout patients from healthy volunteers.